Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma
Clinical trial NCT03927274 · TERMINATED
Trial details
- NCT number
- NCT03927274
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2023-05-24
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.